Suppliers / Nanjing Heron Pharmaceutical

Nanjing Heron Pharmaceutical

China Updated 9 July 2026

Nanjing Heron Pharmaceutical is an API manufacturer based in China. It holds 3 active US drug master files and one valid CEP across a filed portfolio of 4 molecules.

3
active US DMFs
1
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Nanjing, China Not on file

What they file, and where

Molecule Regulators Docs
Alfacalcidol EDQM 1
Calcipotriol US FDA 1
Paricalcitol US FDA 1
Regadenoson US FDA 1

Also appears on these molecule pages

Questions about Nanjing Heron Pharmaceutical

Does Nanjing Heron Pharmaceutical hold a US DMF or a CEP?
Nanjing Heron Pharmaceutical holds 3 active US drug master files and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Nanjing Heron Pharmaceutical manufacture?
1 registered site is on record, in China (Nanjing). Every site is listed on this page with the register it came from.
What does Nanjing Heron Pharmaceutical make?
4 molecules are on record against Nanjing Heron Pharmaceutical, including Alfacalcidol, Calcipotriol, Paricalcitol and Regadenoson. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Nanjing Heron Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability